June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
IGFBP-3 Regulates VEGF through PKCzeta in retinal endothelial cells cultured in high glucose
Author Affiliations & Notes
  • Youde Jiang
    Anatomy and Cell Biology, Wayne State University, Detroit, MI
  • Jena Steinle
    Anatomy and Cell Biology, Wayne State University, Detroit, MI
  • Footnotes
    Commercial Relationships Youde Jiang, None; Jena Steinle, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 5177. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Youde Jiang, Jena Steinle; IGFBP-3 Regulates VEGF through PKCzeta in retinal endothelial cells cultured in high glucose. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):5177.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Since vascular endothelial cells growth factor (VEGF) is key to diabetic macular edema and can be regulated by insulin-like growth factor binding protein 3 (IGFBP-3), we determined the cellular signaling by which IGFBP-3 can reduce VEGF levels in retinal endothelial cells cultured in both normal and high glucose.

Methods: Primary retinal endothelial cells were cultured in normal (5mM) or high glucose (25mM) with some cells transfected with a mutant IGFBP-3 that does not bind IGF-1. Additional cells were treated with recombinant endothelial nitric oxide synthase (eNOS) or protein kinase C zeta (PKCz) following to transfection with mutant IGFBP-3 to determine the role of eNOS and PKCz in the regulation of VEGF.

Results: VEGF, eNOS and PKCz are all increased in retinal endothelial cells cultured in high glucose, which were reduced by treatment with mutant IGFBP-3. When cells in high glucose were treated with IGFBP-3 and recombinant eNOS, eNOS significantly increased both the phosphorylation of PKCz and VEGF levels, which were reduced by IGFBP-3 transfection. Similar results were obtained in cells treated with IGFBP-3 and recombinant PKCz.

Conclusions: These data demonstrate that VEGF is regulated by IGFBP-3 in vascular cells cultured in high glucose. Furthermore, IGFBP-3 significantly reduces eNOS and PKCz to regulate VEGF. Taken together, this study provides a potential novel signaling pathway to allow for development of treatments for macular edema, in addition to the reduction in VEGF. Targeting upstream signaling pathways may also reduce VEGF-initiated responses in retinal endothelial cells.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×